Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151434 · ClinicalTrials.gov registry record · Phase 3
Comparison of Three Different Pain Blocks for Subjects Undergoing VATS (Video Assisted Thoracoscopic Surgery) Procedure.
A Phase 3 study of Pain, Postoperative and Pain, Acute, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 147
- Enrollment target
- 1
- Study location
NCT03151434: Completed Phase 3 study of Pain, Postoperative and Pain, Acute, sponsored by Indiana University.
NCT03151434 is a Phase 3 study of Pain, Postoperative and Pain, Acute that has completed, run by Indiana University. The registered enrollment target is 147 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03151434, a Phase 3 study of Pain, Postoperative and Pain, Acute, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 147 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare three different pain control methods on subjects who are scheduled to undergo VATS (video-assisted thoracoscopic surgery) procedures. The study will compare their pain scores, narcotic needs, patient satisfaction scores, and narcotic side effects.
Primary Outcome
The VAS score will be taken with both rest and movement (knee flexion) and will be measured by a study team investigator using Visual Analog Scale (VAS). Using "units on a scale" of 1-10 for documentation with 10 being the worst pain and 0 being no pain
Conditions Studied
Interventions
- DRUG US Guided Single Shot Paravertebral Block (0.2% ropivicaine infusion)
- DRUG US Guided Paravertebral Catheter (0.2% ropivicaine bolus)
- DRUG Thoracic Epidural (0.125% bupivicaine/hydromorphone)
Study Locations (1)
Indiana
- Indiana University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2018-07-30 |
| Phase | Phase 3 |
What the finished NCT03151434 record still lists
NCT03151434 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (46% lower).
The record links to 3 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 3 interventions - of which US Guided Single Shot Paravertebral Block (0.2% ropivicaine infusion) is the first listed.
NCT03151434 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03151434 about?
NCT03151434 is a clinical study titled "Comparison of Three Different Pain Blocks for Subjects Undergoing VATS (Video Assisted Thoracoscopic Surgery) Procedure.". The purpose of this study is to compare three different pain control methods on subjects who are scheduled to undergo VATS (video-assisted thoracoscopic surgery) procedures. The study will compare their pain scores, narcotic needs, patient satisfaction scores, and narcotic side effects.
What is the current status of trial NCT03151434?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 147 participants. The study started on 2017-02-07. Estimated completion is 2018-07-30.
What conditions does trial NCT03151434 study?
This clinical trial studies the following conditions: Pain, Postoperative, Pain, Acute, Video Assisted Thoracoscopic Surgery.
What interventions are being tested in trial NCT03151434?
The interventions under investigation include: US Guided Single Shot Paravertebral Block (0.2% ropivicaine infusion) (DRUG), US Guided Paravertebral Catheter (0.2% ropivicaine bolus) (DRUG), Thoracic Epidural (0.125% bupivicaine/hydromorphone) (DRUG).
Who is sponsoring clinical trial NCT03151434?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03151434 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03151434's enrollment target sits among peer trials
147 28th of 113 higher than 85 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
COMPLETED · Phase 3
-
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
COMPLETED · Phase 3
-
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI